Position
Fidelity in Larimar Therapeutics, Inc.
Back to the book · All holders of LRMR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$92.2K$4.50 → $3.05
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12.9K | $49.1K | — | — | — | 0.0% |
| Q1 2026 | 63.6K | $286.1K | $4.50 | $8.89K | $228.1K | 0.0% |
| Q2 2026 | 937.4K | $2.86M | $3.05 | −$92.2K | $2.67M | 0.0% |